Alzheimer's disease medication and risk of all‐cause mortality and all‐cause hospitalization: A retrospective cohort study-Reference-Cited by-同舟云学术

Alzheimer's disease medication and risk of all‐cause mortality and all‐cause hospitalization: A retrospective cohort study

Published:2019-01 Issue:1 Volume:5 Page:294-302
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Bhattacharjee Sandipan¹,Patanwala Asad E.²,Lo‐Ciganic Wei‐Hsuan³,Malone Daniel C.¹,Lee Jeannie K.¹,Knapp Shannon M.⁴,Warholak Terri¹,Burke William J.⁵⁶⁷

Affiliation:

1. Department of Pharmacy Practice and ScienceCollege of Pharmacy, The University of ArizonaTucsonAZUSA

2. The University of Sydney School of Pharmacy, Royal Prince Alfred HospitalFaculty of Medicine and HealthThe University of SydneyNSWAustralia

3. Department of Pharmaceutical Outcomes & PolicyCollege of Pharmacy, University of FloridaGainesvilleFLUSA

4. Statistics Consulting LaboratoryBio5 Institute, The University of ArizonaTucsonAZUSA

5. Banner Alzheimer's InstitutePhoenixAZUSA

6. Department of PsychiatryUniversity of Arizona College of MedicinePhoenixAZUSA

7. Arizona Alzheimer's ConsortiumPhoenixAZUSA

Funder

Alzheimer's Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.05.005

Reference52 articles.

1. K.D.Kochanek J.Xu andB.Tejada‐Vera.Deaths: Final Data for 2014. National Vital Statistics Report Available from:https://www.cdc.gov/nchs/data/nvsr/nvsr65/nvsr65_04.pdf 2016Accessed September 26 2018.

2. Alzheimer's Association.2017 Alzheimer's Disease Facts and Figures Available from:https://www.alz.org/documents_custom/2017‐facts‐and‐figures.pdf 2017Accessed August 24 2018.

3. Burden of Alzheimer's disease and association with negative health outcomes;Malone D.C.;Am J Manag Care,2009

4. Update on the Pharmacological Treatment of Alzheimers Disease

5. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noninvasive vs invasive respiratory support for patients with acute hypoxemic respiratory failure;PLOS ONE;2024-09-06

2. Acute Respiratory Failure From Early Pandemic COVID-19;CHEST Critical Care;2024-03

3. Noninvasive vs Invasive Respiratory Support for Patients with Acute Hypoxemic Respiratory Failure;2023-12-28

4. Synthesis and evaluation of Fmoc-amino esters and amides bearing a substrate like quaternary ammonium group as selective butyrylcholinesterase inhibitors;Bioorganic & Medicinal Chemistry Letters;2023-08

5. Donepezil-associated survival benefits among Alzheimer’s disease patients are retained but not enhanced during COVID-19 infections;Therapeutic Advances in Infectious Disease;2023-01